November 13, 2025
1 min read

Investigational Merck Pill, Enlicitide, Cuts ‘Bad’ Cholesterol by 60%, Potentially Replacing Injections

THURSDAY, Nov. 13, 2025 A new investigational pill from Merck could change how millions of people treat high cholesterol and help prevent heart attacks and stro

Leave a Reply

Your email address will not be published.

Previous Story

New Merck Pill Cuts ‘Bad’ Cholesterol by 60%, Potentially Replacing Injections

Next Story

Wild poliovirus detected in Germany

Previous Story

New Merck Pill Cuts ‘Bad’ Cholesterol by 60%, Potentially Replacing Injections

Next Story

Wild poliovirus detected in Germany

Latest from Blog

Go toTop